Janux Therapeutics, Inc.
JANX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $48 | $52 | $74 | $431 |
| Short-Term Investments | $941 | $944 | $940 | $595 |
| Receivables | $6 | $6 | $6 | $5 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $4 | $4 | $3 |
| Total Curr. Assets | $998 | $1,006 | $1,023 | $1,034 |
| Property Plant & Equip (Net) | $23 | $23 | $24 | $24 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $1 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $3 | $4 | $4 |
| Total NC Assets | $27 | $27 | $27 | $28 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,025 | $1,032 | $1,051 | $1,062 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $2 | $4 |
| Short-Term Debt | $2 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $22 | $16 | $13 | $12 |
| Total Curr. Liab. | $28 | $21 | $18 | $17 |
| LT Debt | $20 | $20 | $21 | $21 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $20 | $20 | $21 | $21 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $20 | $22 | $23 | $23 |
| Total Liabilities | $48 | $42 | $38 | $39 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$319 | -$295 | -$261 | -$238 |
| AOCI | $5 | $4 | $4 | $2 |
| Other Equity | $1,291 | $1,282 | $1,270 | $1,258 |
| Total Equity | $977 | $991 | $1,012 | $1,023 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,025 | $1,032 | $1,051 | $1,062 |
| Net Debt | -$26 | -$30 | -$51 | -$408 |